Recent Quotes (30 days)

You have no recent quotes
chg | %

Consort Medical plc  

(Public, LON:CSRT)   Watch this stock  
Find more results forCSRT
798.50
+3.50 (0.44%)
Jun 19 - Close
LON real-time data - Disclaimer
Currency in GBX unless noted
Range 786.70 - 805.00
52 week 625.00 - 849.00
Open 791.50
Vol / Avg. 30,419.00/19,810.00
Mkt cap 233.15M*
P/E 19.13
Div/yield 12.71/2.47*
EPS 0.42*
Shares 29.20M
Beta     -
Inst. own     -
*GBP
Sep 2, 2013
Consort Medical PLC Annual General Meeting Add to calendar
Jun 27, 2013
Preliminary 2012 Consort Medical PLC Earnings Release Add to calendar
Jun 13, 2013
Preliminary 2012 Consort Medical PLC Earnings Presentation
Mar 26, 2013
Consort Medical PLC Bespak Site Visit
  

Key stats and ratios

Q4 (Oct '12) 2012
Net profit margin 9.67% 10.04%
Operating margin 13.75% 14.47%
EBITD margin - 20.29%
Return on average assets 7.55% 8.10%
Return on average equity 15.04% 16.66%
Employees 1,163 -
Carbon Disclosure Rating - -

Address

Ground floor, Suite D, Breakspear Park, Breakspear Way
HEMEL HEMPSTEAD, ENG HP2 4TZ
United Kingdom - Map
+44-1442-867920 (Phone)
+44-1442-245237 (Fax)

Website links

External links

Analyst Estimates - BusinessWeek
Options - MarketWatch
Director Dealings - Yahoo Finance
Discussion Group - Google Finance

Description

Consort Medical plc is a healthcare company focused on medical technologies. The principal activities of the Company are the design, development and manufacture of specialty medical drug delivery devices and services to the pharmaceutical industry through its Bespak Division and disposable airway management products for critical care settings in hospitals and pre-hospital settings through its King Systems Division. The Company�s products include metered dose inhalers, dry powder devices, actuators, compliance aids, disposable autoinjectors, needlefree reusable jet injectors, disposable facemasks, breathing circuits, laryngeal tubes and video laryngoscopes. The Company operates through two divisions: Bespak which consists of respiratory and an injectables business; and King Systems, a United States-based anaesthesia products business. In February 2013, it announced the disposal of its King Systems division (King).

Officers and directors

Jonathan Glenn Chief Executive, Executive Director
Age: 43
Richard Cotton Group Finance Director, Executive Director
John Slater General Counsel, Company Secretary
Nick Higgins Corporate Development Director, Executive Director
Age: 55
Peter J. Fellner Ph.D. Non-Executive Independent Chairman of the Board
Age: 70
Steve Crummett Non-Executive Director
Ian J. Nicholson Non-Executive Director
Lynn Drummond Non-Executive Independent Director
Age: 53
William J. Jenkins M.D. Senior Non-Executive Independent Director
Age: 64